Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174033 | SCV000225265 | benign | not specified | 2015-04-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000405814 | SCV000482069 | uncertain significance | G6PD deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000646701 | SCV000768480 | benign | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000174033 | SCV001157384 | likely benign | not specified | 2018-08-27 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002260999 | SCV002541778 | uncertain significance | not provided | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917610 | SCV004733127 | benign | G6PD-related disorder | 2019-05-23 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |